Literature DB >> 16911036

Cognitive deficits in narcolepsy.

A Naumann1, C Bellebaum, I Daum.   

Abstract

The aim of the investigations was to explore the nature and the severity of cognitive deficits in narcolepsy patients. In two studies, narcolepsy patients were compared with matched control subjects on a range of attention, memory and executive control tasks. Impairments were only observed on attention and executive function tasks which involved higher demands on inhibition or task management abilities whereas relatively routine memory and attention tasks yielded intact performance in narcolepsy patients. The overall pattern of results indicates an executive control deficit in narcolepsy which might be related to a reduction of available cognitive processing resources because of the need for continuous allocation of resources to monitoring and maintenance of vigilance.

Entities:  

Mesh:

Year:  2006        PMID: 16911036     DOI: 10.1111/j.1365-2869.2006.00533.x

Source DB:  PubMed          Journal:  J Sleep Res        ISSN: 0962-1105            Impact factor:   3.981


  36 in total

Review 1.  Orexin/hypocretin modulation of the basal forebrain cholinergic system: Role in attention.

Authors:  J Fadel; J A Burk
Journal:  Brain Res       Date:  2009-08-21       Impact factor: 3.252

2.  Efficacy of THN102 (a combination of modafinil and flecainide) on vigilance and cognition during 40-hour total sleep deprivation in healthy subjects: Glial connexins as a therapeutic target.

Authors:  Fabien Sauvet; Mégane Erblang; Danielle Gomez-Merino; Arnaud Rabat; Mathias Guillard; Dominique Dubourdieu; Hervé Lefloch; Catherine Drogou; Pascal Van Beers; Clément Bougard; Cyprien Bourrrilhon; Pierrick Arnal; Werner Rein; Franck Mouthon; Francoise Brunner-Ferber; Damien Leger; Yves Dauvilliers; Mounir Chennaoui; Mathieu Charvériat
Journal:  Br J Clin Pharmacol       Date:  2019-09-15       Impact factor: 4.335

3.  White and gray matter abnormalities in narcolepsy with cataplexy.

Authors:  Christoph Scherfler; Birgit Frauscher; Michael Schocke; Michael Nocker; Viola Gschliesser; Laura Ehrmann; Markus Niederreiter; Regina Esterhammer; Klaus Seppi; Elisabeth Brandauer; Werner Poewe; Birgit Högl
Journal:  Sleep       Date:  2012-03-01       Impact factor: 5.849

4.  Aging-related deficits in orexin/hypocretin modulation of the septohippocampal cholinergic system.

Authors:  Emily M Stanley; Jim Fadel
Journal:  Synapse       Date:  2012-02-15       Impact factor: 2.562

5.  Increased acetylcholine and glutamate efflux in the prefrontal cortex following intranasal orexin-A (hypocretin-1).

Authors:  Coleman B Calva; Habiba Fayyaz; Jim R Fadel
Journal:  J Neurochem       Date:  2018-01-12       Impact factor: 5.372

Review 6.  The neurophysiological basis of excessive daytime sleepiness: suggestions of an altered state of consciousness.

Authors:  P K Hitchcott; D Menicucci; S Frumento; A Zaccaro; A Gemignani
Journal:  Sleep Breath       Date:  2019-05-28       Impact factor: 2.816

7.  Age-related loss of orexin/hypocretin neurons.

Authors:  B A Kessler; E M Stanley; D Frederick-Duus; J Fadel
Journal:  Neuroscience       Date:  2011-01-22       Impact factor: 3.590

8.  Modafinil improves real driving performance in patients with hypersomnia: a randomized double-blind placebo-controlled crossover clinical trial.

Authors:  Pierre Philip; Cyril Chaufton; Jacques Taillard; Aurore Capelli; Olivier Coste; Damien Léger; Nicholas Moore; Patricia Sagaspe
Journal:  Sleep       Date:  2014-03-01       Impact factor: 5.849

Review 9.  Intranasal administration of orexin peptides: Mechanisms and therapeutic potential for age-related cognitive dysfunction.

Authors:  Coleman B Calva; Jim R Fadel
Journal:  Brain Res       Date:  2018-08-24       Impact factor: 3.252

10.  Working memory in 8 Kleine-Levin syndrome patients: an fMRI study.

Authors:  Maria Engström; Patrick Vigren; Thomas Karlsson; Anne-Marie Landtblom
Journal:  Sleep       Date:  2009-05       Impact factor: 5.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.